Literature DB >> 15309604

Up-regulation of interleukin-2 mRNA in children with idiopathic nephrotic syndrome.

Hironobu Shimoyama1, Mitsuru Nakajima, Hiroyuki Naka, Yoshiyuki Maruhashi, Hideki Akazawa, Taku Ueda, Masayuki Nishiguchi, Yoko Yamoto, Hidekazu Kamitsuji, Akira Yoshioka.   

Abstract

The current hypothesis for the pathogenesis of childhood idiopathic nephrotic syndrome (INS) favors the involvement of a T cell-mediated immune response. Various cytokines derived from T cells may play a critical role in INS. Previous studies have measured serum or urine cytokine levels and suggest an imbalance of the T cell-mediated immune response. To elucidate the true profile of T cell-derived cytokines, we determined interleukin (IL)-2, interferon (IFN)-gamma, IL-4, IL-10, and tumor necrosis factor (TNF)-alpha mRNA expression in children with INS. We collected mRNA from peripheral blood mononuclear cells together with plasma and urine from nine children in the acute and remission phases of INS. Expression of IL-2, IFN-gamma, IL-4, IL-10, and TNF-alpha mRNA was determined by a quantitative real-time PCR assay. Plasma and urine cytokine concentrations were measured using a specific enzyme-linked immunosorbent assay. These data were compared between the acute and remission phase in the same patients. The IL-2 mRNA levels were significantly higher in the acute phase than in the remission phase, whilst no significant difference was found in the other cytokines investigated. There was no significant difference in the plasma and urine cytokine concentrations between the acute and remission phase. Our results indicate increased expression of IL-2 mRNA in the acute phase of INS, suggesting that IL-2, at least in part, might be involved in the pathophysiology of childhood INS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309604     DOI: 10.1007/s00467-004-1569-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  26 in total

1.  Cytokine mRNA quantification by real-time PCR.

Authors:  Patrick Stordeur; Lionel F Poulin; Ligia Craciun; Ling Zhou; Liliane Schandené; Aurore de Lavareille; Stanislas Goriely; Michel Goldman
Journal:  J Immunol Methods       Date:  2002-01-01       Impact factor: 2.303

2.  A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening.

Authors:  Djillali Sahali; André Pawlak; Asta Valanciuté; Philippe Grimbert; Philippe Lang; Philippe Remy; Albert Bensman; Georges Guellën
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

3.  Recombinant interleukin-2 alone did not induce proteinuria with changes in anionic sites of the glomerular basement membrane in rats.

Authors:  S Fujimoto; Y Yamamoto; S Hisanaga; N Yokota; T Eto
Journal:  Nephron       Date:  1992       Impact factor: 2.847

4.  Th1/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome.

Authors:  J Stachowski; C Barth; J Michałkiewicz; T Krynicki; T Jarmoliński; D Runowski; M Lewandowska-Stachowiak; M Zaniew; A Warzywoda; E Bortkiewicz; M Dobosz; J Maciejewski; C A Baldamus
Journal:  Pediatr Nephrol       Date:  2000-08       Impact factor: 3.714

Review 5.  Management of nephrotic syndrome in childhood.

Authors:  T Melvin; W Bennett
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

Review 6.  Biology of human TH1 and TH2 cells.

Authors:  S Romagnani
Journal:  J Clin Immunol       Date:  1995-05       Impact factor: 8.317

7.  Cytokine mRNA profile in lipoid nephrosis: evidence for increased IL-8 mRNA stability.

Authors:  Paul F Laflam; Soichi Haraguchi; Eduardo H Garin
Journal:  Nephron       Date:  2002-08       Impact factor: 2.847

8.  A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children.

Authors:  A Tejani; M Suthanthiran; A Pomrantz
Journal:  Nephron       Date:  1991       Impact factor: 2.847

9.  Interleukin-12 and interferon-gamma production in childhood idiopathic nephrotic syndrome.

Authors:  V Stefanović; E Golubović; M Mitić-Zlatković; P Vlahović; O Jovanović; R Bogdanović
Journal:  Pediatr Nephrol       Date:  1998-08       Impact factor: 3.714

10.  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

View more
  16 in total

Review 1.  Immune and inflammatory role in renal disease.

Authors:  John D Imig; Michael J Ryan
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

2.  Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor.

Authors:  Anna Wasilewska; Walentyna Zoch-Zwierz; Mirosława Pietruczuk
Journal:  Eur J Pediatr       Date:  2006-09-22       Impact factor: 3.183

3.  Effect of tumor necrosis factor alpha and vascular permeability growth factor on albuminuria in rats.

Authors:  Paul F Laflam; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2005-10-07       Impact factor: 3.714

4.  Nephrotic syndrome preceding psoriasis in children.

Authors:  Arvind Bagga; Shina Menon; Pankaj Hari; Mukta Mantan; Amit Dinda
Journal:  Pediatr Nephrol       Date:  2007-04-25       Impact factor: 3.714

5.  T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS.

Authors:  Chang-Yien Chan; Isaac Desheng Liu; Lourdes Paula Resontoc; Kar-Hui Ng; Yiong-Huak Chan; Perry Yew-Weng Lau; Mya Than; Stanley C Jordan; Kong-Peng Lam; Wee-Song Yeo; Hui-Kim Yap
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-07       Impact factor: 8.237

Review 6.  A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome.

Authors:  Carlos E Araya; Clive H Wasserfall; Todd M Brusko; Wei Mu; Mark S Segal; Richard J Johnson; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

7.  Remission of refractory minimal change nephrotic syndrome after basiliximab therapy.

Authors:  Sung-Shin Park; Won-Ho Hahn; Sung-Do Kim; Byoung-Soo Cho
Journal:  Pediatr Nephrol       Date:  2009-02-26       Impact factor: 3.714

Review 8.  Idiopathic nephrotic syndrome and atopy: is there a common link?

Authors:  Maher Abdel-Hafez; Michiko Shimada; Pui Y Lee; Richard J Johnson; Eduardo H Garin
Journal:  Am J Kidney Dis       Date:  2009-06-25       Impact factor: 8.860

9.  Activation of the acute inflammatory phase response in idiopathic nephrotic syndrome: association with clinicopathological phenotypes and with response to corticosteroids.

Authors:  Neus Roca; Cristina Martinez; Elias Jatem; Alvaro Madrid; Mercedes Lopez; Alfons Segarra
Journal:  Clin Kidney J       Date:  2021-03-30

10.  Multidimensional inflammatory and immunological endotypes of idiopathic focal segmental glomerulosclerosis and their association with treatment outcomes.

Authors:  Neus Roca; Alvaro Madrid; Mercedes Lopez; Gloria Fraga; Elias Jatem; Jorge Gonzalez; Cristina Martinez; Alfons Segarra
Journal:  Clin Kidney J       Date:  2020-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.